# CACNA2D1

## Overview
The CACNA2D1 gene encodes the calcium voltage-gated channel auxiliary subunit alpha2delta 1 (α2δ-1), a critical component of voltage-gated calcium channels (VGCCs). This protein functions as an auxiliary subunit, playing a pivotal role in modulating the biophysical properties and trafficking of these channels, which are essential for calcium ion influx in response to membrane depolarization. The α2δ-1 subunit is involved in the regulation of L-type calcium channels (LTCCs) and CaV2 channels, influencing processes such as neurotransmitter release, muscle contraction, and synapse formation (Dolphin2016Voltage‐gated; Zamponi2015The). Structurally, α2δ-1 is characterized by a von Willebrand factor A domain and Cache domains, and it undergoes significant post-translational modifications, including glycosylation, which are crucial for its function and interaction with other proteins (Dahimene2022Biallelic; Dolphin2020Presynaptic). The protein is also a pharmacological target for gabapentinoid drugs, which are used in the treatment of epilepsy and neuropathic pain (Vergult2014Genomic). Mutations in CACNA2D1 have been implicated in various clinical conditions, including cardiac arrhythmias, psychiatric disorders, and glaucoma, highlighting its significance in human health and disease (Andrade2019Genetic; Zhang2021In; Chintalapudi2017Systems).

## Structure
The CACNA2D1 gene encodes the α2δ-1 protein, a subunit of voltage-gated calcium channels. This protein is crucial for modulating channel function and trafficking. The α2δ-1 protein is initially synthesized as a pre-protein in the endoplasmic reticulum, where it undergoes glycosylation and proteolytic cleavage into two polypeptides, α2 and δ, which remain disulfide-bonded (Dahimene2022Biallelic; Dolphin2020Presynaptic). The α2 subunit is heavily glycosylated and projects into the extracellular space, while the δ subunit is linked to the membrane by a glycosylphosphatidylinositol (GPI) anchor (Catterall2020Structure).

Structurally, the α2δ-1 protein contains a von Willebrand factor A domain and four Ca2+ channel and chemotaxis receptor (Cache) domains, organized into two double-Cache (dCache) domains (Dahimene2022Biallelic). The protein's tertiary structure allows it to form a complex with other channel subunits, contributing to the quaternary structure of the voltage-gated calcium channels (Dolphin2020Presynaptic). Post-translational modifications, such as glycosylation, are significant for its function and trafficking (Dolphin2020Presynaptic). The α2δ-1 protein is also a target for gabapentinoid drugs, which are used in anti-epileptic treatments (Vergult2014Genomic).

## Function
The CACNA2D1 gene encodes the α2δ-1 subunit, an auxiliary component of voltage-gated calcium channels, which are crucial for calcium ion influx in response to membrane depolarization. This subunit is involved in the trafficking and expression of these channels, particularly the L-type calcium channels (LTCCs) such as CaV1.1 in skeletal muscle and CaV1.2 in cardiac and smooth muscle, as well as CaV2 channels in the nervous system (Dolphin2016Voltage‐gated; Zamponi2015The). The α2δ-1 subunit enhances the forward trafficking of channel complexes to the plasma membrane, increasing their density and thus facilitating proper calcium signaling (Dolphin2016Voltage‐gated; Zamponi2015The).

In healthy cells, the α2δ-1 subunit plays a critical role in modulating calcium channel function by increasing current density and affecting biophysical parameters such as inactivation kinetics. It also enhances the coupling of channel opening to changes in voltage, which is essential for processes like neurotransmitter release, muscle contraction, and synapse formation (Geisler2015Emerging; Zamponi2015The). The subunit is widely expressed in excitable cells, including those in the central and peripheral nervous systems, and is involved in synaptic function and gene expression regulation (Geisler2015Emerging).

## Clinical Significance
Mutations and alterations in the CACNA2D1 gene are associated with several clinical conditions. The CACNA2D1 S755T mutation is linked to Short QT Syndrome (SQTS), specifically the SQTS6 variant. This mutation results in a 'loss-of-function' effect on the L-type calcium current, leading to shortened QT intervals and an increased risk of arrhythmias and sudden cardiac death (Zhang2021In). 

In the context of psychiatric disorders, genetic studies have implicated CACNA2D1 in major depressive disorder, bipolar disorder, and schizophrenia. Specific single nucleotide polymorphisms (SNPs) in CACNA2D1 have been associated with depressive traits and bipolar disorder with comorbid binge eating (Andrade2019Genetic).

CACNA2D1 is also involved in the regulation of intraocular pressure (IOP) and is a candidate gene for glaucoma susceptibility. Variations in this gene have been linked to primary open-angle glaucoma, with studies suggesting that targeting CACNA2D1 could be effective in lowering IOP (Chintalapudi2017Systems).

Additionally, disruptions in CACNA2D1 have been observed in patients with epilepsy and intellectual disability, indicating a potential link between these conditions and the gene (Mayo2023NType; Vergult2014Genomic).

## Interactions
The CACNA2D1 gene encodes the α2δ-1 protein, a subunit of voltage-gated calcium channels (VGCCs), which plays a significant role in modulating calcium channel function and synaptic transmission. α2δ-1 interacts with various proteins, influencing both presynaptic and postsynaptic activities. It is known to interact with thrombospondin-4 (TSP-4), which enhances calcium currents and contributes to synaptogenesis, particularly in the context of neuropathic pain (Ablinger2020Neuronal). α2δ-1 also forms complexes with α-neurexins, regulating presynaptic calcium influx through CaV2.1 channels, and interacts with synaptic cell-adhesion molecules and extracellular matrix proteins, which are crucial for synaptic organization and function (Ablinger2020Neuronal).

In addition, α2δ-1 specifically interacts with NMDA receptor (NMDAR) subtypes, such as GluN1, GluN2A, and GluN2B, enhancing presynaptic NMDAR trafficking and affecting synaptic glutamate release. This interaction is specific to α2δ-1, as α2δ-2 and α2δ-3 do not co-immunoprecipitate with NMDARs (Ablinger2020Neuronal). These interactions highlight the role of α2δ-1 in modulating synaptic transmission and its potential involvement in neurological disorders. However, the context does not provide specific details on interactions with nucleic acids.


## References


[1. (Geisler2015Emerging) Stefanie Geisler, Clemens L. Schöpf, and Gerald J. Obermair. Emerging evidence for specific neuronal functions of auxiliary calcium channel α2δ subunits. General physiology and biophysics, 34(02):105–118, 2015. URL: http://dx.doi.org/10.4149/gpb_2014037, doi:10.4149/gpb_2014037. This article has 70 citations and is from a peer-reviewed journal.](https://doi.org/10.4149/gpb_2014037)

[2. (Zhang2021In) Shugang Zhang, Weigang Lu, Fei Yang, and Zhiqiang Wei. In silico investigation of cacna2d1 s755t mutation associated with short qt syndrome. IEEE Access, 9:75375–75384, 2021. URL: http://dx.doi.org/10.1109/access.2021.3082174, doi:10.1109/access.2021.3082174. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1109/access.2021.3082174)

[3. (Mayo2023NType) Sonia Mayo, Irene Gómez-Manjón, Ana Victoria Marco-Hernández, Francisco Javier Fernández-Martínez, Ana Camacho, and Francisco Martínez. N-type ca channel in epileptic syndromes and epilepsy: a systematic review of its genetic variants. International Journal of Molecular Sciences, 24(7):6100, March 2023. URL: http://dx.doi.org/10.3390/ijms24076100, doi:10.3390/ijms24076100. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24076100)

[4. (Chintalapudi2017Systems) Sumana R. Chintalapudi, Doaa Maria, Xiang Di Wang, Jessica N. Cooke Bailey, Rand Allingham, Murray Brilliant, Don Budenz, John Fingert, Douglas Gaasterland, Teresa Gaasterland, Jonathan L. Haines, Lisa Hark, Michael Hauser, Rob Igo, Jae Hee Kang, Peter Kraft, Richard Lee, Paul Lichter, Yutao Liu, Syoko Moroi, Louis R. Pasquale, Margaret Pericak-Vance, Anthony Realini, Doug Rhee, Julia R. Richards, Robert Ritch, Joel Schuman, William K. Scott, Kuldev Singh, Arthur Sit, Douglas Vollrath, Gadi Wollstein, Don Zack, Tin Aung, Peter Bonnemaijer, Cheng-Yu Cheng, Jamie Craig, Cornelia van Duijn, Puya Gharahkhani, Adriana Iglesias Gonzalez, Christopher J. Hammond, Alex Hewitt, Rene Hoehn, Fridbert Jonansson, Anthony Khawaja, Chiea Chuen Khor, Caroline C. W. Klaver, Andrew Lotery, David Mackey, Stuart MacGregor, Calvin Pang, Francesca Pasutto, Kári Stefansson, Gudmar Thorleifsson, Unnar Thorsteinsdottir, Veronique Vitart, Eranga Vithana, Terri Young, Tanja Zeller, Pirro G. Hysi, Janey L. Wiggs, Robert W. Williams, and Monica M. Jablonski. Systems genetics identifies a role for cacna2d1 regulation in elevated intraocular pressure and glaucoma susceptibility. Nature Communications, November 2017. URL: http://dx.doi.org/10.1038/s41467-017-00837-5, doi:10.1038/s41467-017-00837-5. This article has 46 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-017-00837-5)

[5. (Dolphin2016Voltage‐gated) Annette C. Dolphin. Voltage‐gated calcium channels and their auxiliary subunits: physiology and pathophysiology and pharmacology. The Journal of Physiology, 594(19):5369–5390, July 2016. URL: http://dx.doi.org/10.1113/JP272262, doi:10.1113/jp272262. This article has 378 citations.](https://doi.org/10.1113/JP272262)

[6. (Dahimene2022Biallelic) Shehrazade Dahimene, Leonie von Elsner, Tess Holling, Lauren S Mattas, Jess Pickard, Davor Lessel, Kjara S Pilch, Ivan Kadurin, Wendy S Pratt, Igor B Zhulin, Hongzheng Dai, Maja Hempel, Maura R Z Ruzhnikov, Kerstin Kutsche, and Annette C Dolphin. Biallelic cacna2d1 loss-of-function variants cause early-onset developmental epileptic encephalopathy. Brain, 145(8):2721–2729, March 2022. URL: http://dx.doi.org/10.1093/brain/awac081, doi:10.1093/brain/awac081. This article has 24 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awac081)

[7. (Catterall2020Structure) William A. Catterall, Michael J. Lenaeus, and Tamer M. Gamal El-Din. Structure and pharmacology of voltage-gated sodium and calcium channels. Annual Review of Pharmacology and Toxicology, 60(1):133–154, January 2020. URL: http://dx.doi.org/10.1146/annurev-pharmtox-010818-021757, doi:10.1146/annurev-pharmtox-010818-021757. This article has 172 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1146/annurev-pharmtox-010818-021757)

[8. (Zamponi2015The) Gerald W. Zamponi, Joerg Striessnig, Alexandra Koschak, and Annette C. Dolphin. The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacological Reviews, 67(4):821–870, September 2015. URL: http://dx.doi.org/10.1124/pr.114.009654, doi:10.1124/pr.114.009654. This article has 803 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1124/pr.114.009654)

[9. (Dolphin2020Presynaptic) Annette C. Dolphin and Amy Lee. Presynaptic calcium channels: specialized control of synaptic neurotransmitter release. Nature Reviews Neuroscience, 21(4):213–229, March 2020. URL: http://dx.doi.org/10.1038/s41583-020-0278-2, doi:10.1038/s41583-020-0278-2. This article has 162 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41583-020-0278-2)

[10. (Andrade2019Genetic) Arturo Andrade, Ashton Brennecke, Shayna Mallat, Julian Brown, Juan Gomez-Rivadeneira, Natalie Czepiel, and Laura Londrigan. Genetic associations between voltage-gated calcium channels and psychiatric disorders. International Journal of Molecular Sciences, 20(14):3537, July 2019. URL: http://dx.doi.org/10.3390/ijms20143537, doi:10.3390/ijms20143537. This article has 59 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20143537)

[11. (Vergult2014Genomic) Sarah Vergult, Annelies Dheedene, Alfred Meurs, Fran Faes, Bertrand Isidor, Sandra Janssens, Agnès Gautier, Cédric Le Caignec, and Björn Menten. Genomic aberrations of the cacna2d1 gene in three patients with epilepsy and intellectual disability. European Journal of Human Genetics, 23(5):628–632, July 2014. URL: http://dx.doi.org/10.1038/ejhg.2014.141, doi:10.1038/ejhg.2014.141. This article has 54 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2014.141)

[12. (Ablinger2020Neuronal) Cornelia Ablinger, Stefanie M. Geisler, Ruslan I. Stanika, Christian T. Klein, and Gerald J. Obermair. Neuronal α2δ proteins and brain disorders. Pflügers Archiv - European Journal of Physiology, 472(7):845–863, June 2020. URL: http://dx.doi.org/10.1007/s00424-020-02420-2, doi:10.1007/s00424-020-02420-2. This article has 38 citations.](https://doi.org/10.1007/s00424-020-02420-2)